Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbial Metabolites: Critical Regulators in NAFLD
Xin Dai, Huiqin Hou, Wanru Zhang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort
Jesse A. Goodrich, Douglas I. Walker, Xiangping Lin, et al.
JHEP Reports (2022) Vol. 4, Iss. 10, pp. 100550-100550
Open Access | Times Cited: 76
Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol
Ming Yang, Xiaoqiang Qi, Nan Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy
Bo Tang, Li Tang, Shengpeng Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 44
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 25
Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
Qichen Long, Fengming Luo, Binghui Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 18
Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
Ameng Shi, Ting Li, Ying Zheng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 96
Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis
Vali Musazadeh, Neda Roshanravan, Parvin Dehghan, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 39
Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Xiangyu Zhou, Jincheng Wang, Sufang Zhou, et al.
Medicine (2023) Vol. 102, Iss. 4, pp. e32734-e32734
Open Access | Times Cited: 25
Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota
Feiwei Cao, Qinchao Ding, Hui Zhuge, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 23
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism
Isabel Cornejo‐Pareja, Mohamed Reda Amiar, Luís Ocaña-Wilhelmi, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 4, pp. 329-341
Open Access | Times Cited: 9
Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis
Wenpin Cai, Ting Qiu, Weitao Hu, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299946-e0299946
Open Access | Times Cited: 8
Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases
Chao‐Yue Sun, Zuo-Liang Zheng, Cunwu Chen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 34
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 550-550
Open Access | Times Cited: 31
Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
Salvatore Pezzino, Maria Sofia, Gloria Faletra, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1622-1622
Open Access | Times Cited: 31
Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
Qin Guo, Yun Li, Xin Dai, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3722-3722
Open Access | Times Cited: 17
A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis
Li Hu, Mingjie Wang, Peizhan Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116617-116617
Open Access | Times Cited: 5
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4857-4857
Open Access | Times Cited: 5
Litchi-Derived Polyphenol Alleviates Liver Steatosis and Gut Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blinded, Placebo-Controlled Study
Thananya Jinato, Maneerat Chayanupatkul, Thasinas Dissayabutra, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2921-2921
Open Access | Times Cited: 23
Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
Jorum Kirundi, Sheida Moghadamrad, Camilla Urbaniak
World Journal of Gastroenterology (2023) Vol. 29, Iss. 11, pp. 1651-1668
Open Access | Times Cited: 15
Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective
Lijun Luo, Yongchun Chang, Sheng Li
Life Sciences (2023) Vol. 321, pp. 121614-121614
Closed Access | Times Cited: 14
Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD
Nantawat Satthawiwat, Thananya Jinato, Sawannee Sutheeworapong, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1800-1800
Open Access | Times Cited: 4
Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity
Jing Lu, Dilireba Shataer, Huizhen Yan, et al.
Foods (2024) Vol. 13, Iss. 18, pp. 2992-2992
Open Access | Times Cited: 4
The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases
Eliane Münte, Phillipp Hartmann
Biomolecules (2025) Vol. 15, Iss. 4, pp. 469-469
Open Access
Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
Nicolas Lanthier, Nathalie M. Delzenne
Cells (2022) Vol. 11, Iss. 17, pp. 2718-2718
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top